The role of poly (ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes

P Pacher, L Liaudet, FG Soriano, JG Mabley… - Diabetes, 2002 - Am Diabetes Assoc
Patients with diabetes exhibit a high incidence of diabetic cardiomyopathy and vascular
complications, which underlie the development of retinopathy, nephropathy, and neuropathy …
被引用次数：372 相关文章

The role of poly (ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes

P Pacher, L Liaudet, FG Soriano, JG Mabley… - …, 2002 - pubmed.ncbi.nlm.nih.gov
Patients with diabetes exhibit a high incidence of diabetic cardiomyopathy and vascular
complications, which underlie the development of retinopathy, nephropathy, and neuropathy …

[引用][C] The role of poly (ADP-Ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes

P Pacher, L Liaudet, FG Soriano, JG Mabley, É Szabó… - Diabetes, 2002 - repositorio.usp.br
ReP USP - Detalhe do registro: The role of poly (ADP-Ribose) polymerase activation in the
development of myocardial and endothelial dysfunction in diabetes Home About USP Schools …

The role of poly (ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes.

P Pacher, L Liaudet, FG Soriano, JG Mabley, E Szabó… - Diabetes, 2002 - europepmc.org
Patients with diabetes exhibit a high incidence of diabetic cardiomyopathy and vascular
complications, which underlie the development of retinopathy, nephropathy, and neuropathy …

The role of poly (ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes

P Pacher, L Liaudet, FG Soriano, JG Mabley - Diabetes, 2002 - search.proquest.com
Patients with diabetes exhibit a high incidence of diabetic cardiomyopathy and vascular
complications, which underlie the development of retinopathy, nephropathy, and neuropathy …
[PDF] psu.edu

[PDF][PDF] The Role of Poly (ADP-Ribose) Polymerase Activation in the Development of Myocardial and Endothelial Dysfunction in Diabetes

P Pacher, L Liaudet, FG Soriano, JG Mabley, E Szabo… - DIABETES, 2002 - Citeseer
The Role of Poly(ADP-Ribose) Polymerase Activation in the Development of Myocardial and
Endothelial Dysfunction in Diabetes Page 1 The Role of Poly(ADP-Ribose) Polymerase …

The role of poly (ADP-Ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes

P Pacher, L Liaudet, FG Soriano, J Mabley… - …, 2002 - research.brighton.ac.uk
Patients with diabetes exhibit a high incidence of diabetic cardiomyopathy and vascular
complications, which underlie the development of retinopathy, nephropathy, and neuropathy …

The role of poly (ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes

P Pacher, L Liaudet, FG Soriano, JG Mabley, E Szabo… - Diabetes, 2002 - go.gale.com
RESEARCH DESIGN AND METHODS The investigation conformed to the Guide for the
Care and Use of Laboratory Animals published by US National Institutes of Health (NIH …

The Role of Poly (ADP-Ribose) Polymerase Activation in the Development of Myocardial and Endothelial Dysfunction in Diabetes

P Pacher, L Liaudet, FG Soriano, JG Mabley, E Szabó… - Diabetes, 2002 - cir.nii.ac.jp
抄録< jats: p> Patients with diabetes exhibit a high incidence of diabetic cardiomyopathy and
vascular complications, which underlie the development of retinopathy, nephropathy, and …

The role of poly (ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes

P Pacher, L Liaudet, FG Soriano, JG Mabley… - …, 2002 - researchexperts.utmb.edu
Patients with diabetes exhibit a high incidence of diabetic cardiomyopathy and vascular
complications, which underlie the development of retinopathy, nephropathy, and neuropathy …